Home · For Physicians · Neurology
Neurology
ENFD testing for neurology practices
ENFD (also called intraepidermal nerve fiber density, or IENFD) testing uses a minimally invasive 3-mm skin punch biopsy — performed at CLIA-certified laboratories — to directly visualize and quantify small sensory nerve fibers in the epidermis.
Guideline
EFNS/PNS 2010.
The European Federation of Neurological Societies and the Peripheral Nerve Society guideline (2010) gives distal leg skin biopsy with intraepidermal nerve fiber density quantification its highest recommendation level (Level A) for diagnosing small fiber neuropathy.
“Distal leg skin biopsy with quantification of the linear density of intraepidermal nerve fibers (IENF), using generally agreed upon counting rules, is a reliable and efficient technique to assess the diagnosis of SFN (Recommendation Level A).”
ROC analysis: IENFD alone yields ~0.80 sensitivity / 0.82 specificity; combined with sub-epidermal nerve plexus density, sensitivity improves to ~0.92 (Vlckova-Moravcova et al., 2008).
The report
What the ENFD evaluation includes.
Test: ENFD – Epidermal Nerve Fiber Density with PGP9.5 antibody, with H&E, and Congo Red Stain for Amyloidosis.
Reports include PGP9.5 immunohistochemical nerve fiber density and Congo Red stain for amyloid for each biopsy site.
Reports are typically returned within 10–15 business days.
Standard biopsy locations
- Proximal arm
- Distal arm
- Proximal thigh
- Distal thigh
- Calf
- Ankle
- Foot

A close-up of microscope eyepieces in a laboratory. This is a generic lab photograph, not a diagnostic image or a patient sample.
Terminology and context
ENFD, IENFD, and large-fiber studies.
EMG/NCS only evaluate large myelinated fibers, so patients with painful small fiber neuropathy routinely test “normal” on those studies alone.
When nerve conduction studies and EMG, which only assess large fibers, come back normal in a patient with burning, tingling, or numbness, ENFD is often the test that finally confirms small fiber neuropathy (SFN) and gives you an objective, reportable diagnosis to act on.
A normal skin biopsy result does not, by itself, rule out small fiber neuropathy. Biopsy findings should be interpreted in the context of the patient’s full clinical presentation.
This overview is not intended to replace independent review of the primary sources or current test/coverage policies, which should be verified with the performing laboratory and individual payers.
The laboratory offers in-office staff training for the ENFD procedure.